Anti-HDAC9 antibody [EPR5223] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal HDAC9 antibody. Carrier free. Suitable for IHC-P, ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
HDAC7, HDAC7B, HDRP, KIAA0744, MITR, HDAC9, Histone deacetylase 9, HD9, Histone deacetylase 7B, Histone deacetylase-related protein, MEF2-interacting transcription repressor MITR, HD7, HD7b
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HDAC9 antibody [EPR5223] - BSA and Azide free (AB239979)
This data was developed using ab109446, the same antibody clone in a different buffer formulation.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cerebrum tissue sections labeling HDAC9 with Purified ab109446 at 1 : 1000 dilution (1.10 μg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) . Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HDAC9 antibody [EPR5223] - BSA and Azide free (AB239979)
This data was developed using ab239979, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of K-562 (Human chronic myelogenous leukemia lymphoblast) cells labeling HDAC9 with Purified ab239979 at 1 : 100 dilution (10 μg/ml). Cells were fixed in 100% Methanol and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-HDAC9 antibody [EPR5223] - BSA and Azide free (AB239979)
This data was developed using ab239979, the same antibody clone in a different buffer formulation.
Flow Cytometry analysis of K-562 (Human chronic myelogenous leukemia lymphoblast) cells labelling HDAC9 with Purified ab239979 at 1 : 100 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1 : 2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabelled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Lab
Western blot - Anti-HDAC9 antibody [EPR5223] - BSA and Azide free (AB239979)
This data was developed using ab109446, the same antibody clone in a different buffer formulation.
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : HDAC9 (KO) knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HepG2 whole cell lysate (20 μg)
Lane 4 : Raji whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109446 observed at 140 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab109446 was shown to specifically recognize HDAC9 in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when HDAC9 knockout samples were usedexamined. Wild-type and HDAC9 knockout samples were subjected to SDS-PAGE. ab109446 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/10,000 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-HDAC9 antibody [EPR5223] (<a href='/en-us/products/primary-antibodies/hdac9-antibody-epr5223-ab109446'>ab109446</a>)
Predicted band size: 111 kDa
Observed band size: 140 kDa
false
- WB
Unknown
Western blot - Anti-HDAC9 antibody [EPR5223] - BSA and Azide free (AB239979)
All lanes:
Western blot - Anti-HDAC9 antibody [EPR5223] (<a href='/en-us/products/primary-antibodies/hdac9-antibody-epr5223-ab109446'>ab109446</a>) at 1/1000 dilution
Lane 1:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 111 kDa
false
Related conjugates and formulations (10)
-
Anti-HDAC9 antibody [EPR5223]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-HDAC9 antibody [EPR5223]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-HDAC9 antibody [EPR5223]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-HDAC9 antibody [EPR5223]
-
578 PE
PE Anti-HDAC9 antibody [EPR5223]
-
660 APC
APC Anti-HDAC9 antibody [EPR5223]
-
HRP Anti-HDAC9 antibody [EPR5223]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-HDAC9 antibody [EPR5223]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-HDAC9 antibody [EPR5223]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-HDAC9 antibody [EPR5223]
Reactivity data
Product details
ab239979 is the carrier-free version of ab109446.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HDAC9 plays a significant role in regulating gene expression by altering the acetylation status of histones. It participates in the formation of large multiprotein complexes that target specific gene promoters. HDAC9's activity impacts various cellular processes including cell cycle progression and differentiation. It is a part of the CoREST complex which interacts with REST corepressor 1 to modulate neuronal gene expression and synaptic plasticity.
Pathways
HDAC9 is actively involved in key cellular signaling cascades. It contributes to the Notch signaling pathway which has a profound impact on cell differentiation and fate decisions. It also plays a role in the NF-kB pathway which is critical for immune response and inflammation. Through these pathways HDAC9 interacts with proteins such as RBP-Jk in the Notch pathway and IKK complex members in the NF-kB pathway indicating its broad influence on cellular mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Alzheimer's research & therapy 17:47 PubMed39972387
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com